Psilocybin-Research.com Research. Clarity. Progress.

Preparing publication tracker

Psilocybin Research Publication Tracker

Search, analyze, export, and monitor psilocybin and psilocin literature across peer-reviewed papers, preprints, reviews, protocols, and clinical trials.

Database up to date Last update: Jul 3, 2026 01:22 UTC

Database evidence 3,975 indexed records

Indexed records 3,975 SQLite literature index

Published 3,210 Peer-reviewed / formal records

Preprints 478 Marked as not peer reviewed

Clinical trials 287 ClinicalTrials.gov records

Source coverage 8 active sources

Source	Count	Share	Status
Europe PMC	2,554	64.3%	Active
PubMed	302	7.6%	Active
ClinicalTrials.gov	287	7.2%	Active
OpenAlex	283	7.1%	Active
PsyArXiv	216	5.4%	Active
Crossref	157	3.9%	Active
bioRxiv	142	3.6%	Active

Publication timeline 3,072 dated records

3,072 records since 2020

Annual records Cumulative line

3,975Total Publications

3,834Psilocybin Records

553Psilocin Records

142Matching Results

388Journals

66Research Topics

Research search

Reset all

142 matching records Analyze trends Open JSON Open API Download SQLite

Keyword search Author

Substances Psilocybin 3834 Psilocin 553

Date range quick select Last month Last year Last 5 years All time Custom range

BibTeX RIS CSV JSON SQLite

Executed search Sources: bioRxiv 142 matching records are displayed.

Clear search

Latest Publications

Most recently published records currently stored in SQLite.

1-20

Last updated: Jul 3, 2026 01:22 UTC

Checking for newly published papers…

142 matching results

Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens

Entomopathogenic fungi routinely kill their hosts before releasing infectious spores, but select species keep insects alive while sporulating, which enhances dispersal. Transcriptomics and metabolomics studies of entomopathogens with post-mortem dissemination from their parasitized hosts have unraveled infection processes and host responses, yet mechanisms u...

DOI 10.1101/375105

bioRxiv 2018-07-23 Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT.

bioRxiv PREPRINT (not peer reviewed) psilocybin Mechanism of ActionTranscriptomicsMetabolomics Other

Horizontal gene cluster transfer increased hallucinogenic mushroom diversity

Secondary metabolites are heterogeneous natural products that often mediate interactions between species. The tryptophan-derived secondary metabolite, psilocin, is a serotonin receptor agonist that induces altered states of consciousness. A phylogenetically disjunct group of mushroom-forming fungi in the Agaricales produce the psilocin prodrug, psilocybin. S...

DOI 10.1101/176347

bioRxiv 2017-08-14 Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC.

bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin Receptor PharmacologyConsciousnessDrug InteractionsGenomics Other

Email alerts Open a focused sheet to subscribe broadly or narrow notifications by keyword, author, journal, topic, substance, and cited DOI.

Analytics Open a focused analytics workspace for timeline ranges, publication trends, top journals, topics, and authors.

Psilocybin Research Publication Tracker

Research search

Latest Publications

Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study

Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019

Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study

Meskalin / Mescaline

DMT und Ayahuasca / DMT and Ayahuasca

DMT und Ayahuasca / DMT and Ayahuasca

Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia

Meskalin / Mescaline

Usos recreativos, medicinales y etnobotánicos de hongos alucinógenos: una revisión

Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?

Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)

Psilocybin shows mixed results for patients with treatment-resistant depression

Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessation

Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.

Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.

MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.

Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens

Horizontal gene cluster transfer increased hallucinogenic mushroom diversity